BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3085244)

  • 1. [Lymphocyte subpopulations in the hemophilia A population at the La Coruña regional hospital].
    Martínez Cadorniga E; Rodríguez Fernández JM
    Sangre (Barc); 1986; 31(1):83-9. PubMed ID: 3085244
    [No Abstract]   [Full Text] [Related]  

  • 2. [Risk of posttransfusion hepatitis in hemophilia patients].
    Margolina AN; Somova AV; Golosova TV; Pliushch OP; Andreev IuN
    Probl Gematol Pereliv Krovi; 1980 Mar; 25(3):46-8. PubMed ID: 7367412
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hepatitis in hemophilia].
    Eggeling B; Sennekamp J; Brackmann HH; Werner I
    Schweiz Med Wochenschr; 1974 Sep; 104(36):1250-5. PubMed ID: 4445853
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hepatitis and liver disorders in hemophiliac children].
    Tusell J; Ortega JJ; Hernández JM; Piqueras J
    Sangre (Barc); 1983; 28(4):476-85. PubMed ID: 6658638
    [No Abstract]   [Full Text] [Related]  

  • 5. T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates.
    Menitove JE; Aster RH; Casper JT; Lauer SJ; Gottschall JL; Williams JE; Gill JC; Wheeler DV; Piaskowski V; Kirchner P; Montgomery RR
    N Engl J Med; 1983 Jan; 308(2):83-6. PubMed ID: 6401196
    [No Abstract]   [Full Text] [Related]  

  • 6. Commercial factor VIII associated hepatitis, 1974-75, in the United Kingdom: a retrospective survey.
    Craske J; Kirk P; Cohen B; Vandervelde EM
    J Hyg (Lond); 1978 Jun; 80(3):327-36. PubMed ID: 649945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatitis in haemophilia (author's transl)].
    Stampfli K
    Ther Umsch; 1979 Apr; 36(4):322-5. PubMed ID: 377555
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune status of HIV and HCV negative haemophiliacs treated with intermediate-purity factor VIII concentrates.
    Funk M; Ebener U; Kreuz W; Ehrenforth S
    Lancet; 1993 Oct; 342(8876):933-4. PubMed ID: 7692198
    [No Abstract]   [Full Text] [Related]  

  • 9. Estimation of the probability of post transfusion hepatitis in hemophilia treatment.
    Davis CE; Grizzle JE; Bryan JA
    Biometrics; 1973 Jun; 29(2):386-92. PubMed ID: 4709517
    [No Abstract]   [Full Text] [Related]  

  • 10. [Epidemiology of hepatitis in Swiss hemophiliacs].
    Bütler R; Stampfli K
    Schweiz Med Wochenschr; 1979 Oct; 109(39):1449-53. PubMed ID: 556269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of hepatitis-B immunoglobulin to clotting factors.
    Smit Sibinga CT; Das PC; Nieweg HO
    Lancet; 1980 Sep; 2(8193):537. PubMed ID: 6105586
    [No Abstract]   [Full Text] [Related]  

  • 12. Development and persistence of antibody to hepatitis-associated (Australia) antigen in patients with hemophilia.
    Seeler RA; Mufson MA
    J Infect Dis; 1971 Mar; 123(3):279-83. PubMed ID: 5000075
    [No Abstract]   [Full Text] [Related]  

  • 13. Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. Association with hemophiliacs' immune status and blood component usage.
    Jason J; McDougal JS; Holman RC; Stein SF; Lawrence DN; Nicholson JK; Dixon G; Doxey M; Evatt BL
    JAMA; 1985 Jun; 253(23):3409-15. PubMed ID: 2987559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AIDS and preventive treatment in hemophilia.
    Desforges JF
    N Engl J Med; 1983 Jan; 308(2):94-5. PubMed ID: 6216409
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hepatic changes in hemophiliac patients].
    Pérez Bianco PR; García Parra O; Gilbert B; Minoldo D; De Tezanos Pinto M
    Medicina (B Aires); 1981; 41 Suppl():257-61. PubMed ID: 6808290
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cellular immunology status in 5 hemophilic patients with inhibitors subjected to massive therapy with factor VIII concentrate].
    Aznar JA; Jorquera JI; González Molina A; Carbonell F; Trenor A; Sánchez Cuenca JM; de Andrés R
    Sangre (Barc); 1983; 28(5):663-4. PubMed ID: 6420915
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody to hepatitis B surface antigen in haemophiliacs on long-term therapy with Scottish factor VIII.
    Burrell CJ; Black SH; Ramsay DM
    J Clin Pathol; 1978 Apr; 31(4):309-12. PubMed ID: 641208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lymphocyte subpopulations in hemophilia A and B].
    Ollero M; Leal M; Wichman I; García M; Muñoz J; Miranda ML; Jiménez JM; Núñez A; Pascual A; Lissen E
    Med Clin (Barc); 1984 Oct; 83(12):479-81. PubMed ID: 6439957
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatitis in hemophiliacs with multiple transfusions].
    Filová A; Hrubisková K; Hrubisko M; Malícková D; Nováková J; Pokorná G
    Vnitr Lek; 1982 Mar; 28(3):230-6. PubMed ID: 7112967
    [No Abstract]   [Full Text] [Related]  

  • 20. Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions.
    Schimpf K; Mannucci PM; Kreutz W; Brackmann HH; Auerswald G; Ciavarella N; Mösseler J; DeRosa V; Kraus B; Brueckmann C
    N Engl J Med; 1987 Apr; 316(15):918-22. PubMed ID: 3102963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.